Add BrightSurf on Google Email

Could the contraceptive pill reduce risk of ovarian cancer?

Researchers found that women who had used the oral contraceptive pill had a lower risk of ovarian cancer, with a 39% reduced risk for those who had given birth to two or more children. The study also identified certain biomarkers and lifestyle factors associated with a lower risk of ovarian cancer, including lower body weight and short...

SourceUniversity of South Australia·JournalInternational Journal of Gynecological Cancer·TypeData/statistical analysis·DateFeb 2, 2025

Exposure to secondhand cannabis smoke among children

A cross-sectional study found that children exposed to secondhand cannabis smoke at home have significantly higher urinary cannabinoid biomarker levels, indicating increased exposure to toxic and carcinogenic chemicals. Reducing in-home cannabis smoking can substantially reduce child exposure to these harmful substances.

SourceJAMA Network·JournalJAMA Network Open·DateJan 23, 2025

New biomarkers to detect colorectal cancer

Researchers at University of Birmingham have discovered three new protein biomarkers TFF3, LCN2, and CEACAM5 that show strong predictive potential for colorectal cancer. These biomarkers are linked to cell adhesion and inflammation, processes closely associated with cancer development.

SourceUniversity of Birmingham·JournalFrontiers in Oncology·TypeData/statistical analysis·DateJan 20, 2025

Tiny vortexes help detect dangerous viruses

Researchers at Duke University developed an acoustofluidic integrated molecular diagnostics chip, AIMDx, that uses tiny vortexes to detect dangerous viruses. The vortexes trap cells, bacteria, and larger bioparticles, purifying samples for biomedical tests.

SourceDuke University·JournalScience Advances·TypeExperimental study·DateJan 17, 2025

NUS Medicine study: Brain connectome phenotype linked to cerebrovascular disease can track cognitive decline

Researchers discovered a brain functional connectome phenotype related to multiple cerebrovascular disease markers that contributes additively to cognitive decline and neurodegeneration alongside Alzheimer's disease. The study highlights the role of cerebrovascular disease in reshaping our understanding of dementia.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalAlzheimer s & Dementia·TypeExperimental study·DateJan 12, 2025

Standardized nomenclature for bone status indices to enhance diagnostic consistency and clarity

A new position paper from the International Osteoporosis Foundation and International Federation of Clinical Chemistry proposes a unified nomenclature for bone status indices to enhance diagnostic consistency and clarity. The guidelines offer a comprehensive framework to unify terminology and improve comparability across studies.

SourceInternational Osteoporosis Foundation·JournalClinical Chemistry and Laboratory Medicine (CCLM)·TypeLiterature review·DateJan 10, 2025

Researchers shed light on how to predict which skin cancer patients are most likely to respond to immunotherapy

A new study has identified macrophage activity as a key predictor of which skin cancer patients are most likely to respond to immunotherapy. The findings aim to improve personalized medicine for cancer patients and enable clinicians to select effective treatments, reducing side effects and costs.

SourceUniversity of Bath·JournalJCO Oncology Advances·TypeExperimental study·DateJan 8, 2025

USC study finds new evidence linking dementia to problems with the brain’s waste clearance system

A new USC study validates a biomarker linked to vascular dementia and suggests that glymphatic damage drives cognitive decline. The findings provide a potential pathway to explain how cognitive impairment arises, offering a target for clinical researchers seeking treatments for vascular dementia.

SourceKeck School of Medicine of USC·JournalAlzheimer s & Dementia·TypeImaging analysis·DateJan 7, 2025

A speckle of hope for cancer patients

A new study by Katherine Alexander and Shelley Berger has found a possible source of variability in cancer treatment response in clear cell renal cell carcinoma (ccRCC). The researchers identified two distinct patterns of nuclear speckles in kidney tumors, which may correlate with patient outcomes.

SourceCold Spring Harbor Laboratory·JournalNature Cell Biology·DateJan 2, 2025

Study supports new blood-based biomarker to detect early brain changes leading to cognitive impairment and dementia

A new blood-based biomarker, placental growth factor (PlGF), has been identified as a potential tool for detecting early brain changes associated with cognitive impairment and dementia. Elevated PlGF levels were found to be linked to increased vascular permeability, leading to white matter injury and subsequent cognitive decline.

Davos Alzheimer’s Collaborative and pharmaceutical and diagnostics companies work together on Alzheimer’s disease blood biomarker validation

The Davos Alzheimer's Collaborative is partnering with Janssen Research & Development and Beckman Coulter Diagnostics to advance the validation of blood-based biomarkers (BBMs) for Alzheimer's disease. This collaboration aims to develop globally generalizable blood tests that can be used in diverse populations, including those from low...

Study using more reliable measure of wine consumption finds possible protective effect for low to moderate drinking in people at risk of cardiovascular disease

A new study found that low to moderate wine drinking reduces the risk of serious cardiovascular disease by 50% in people at high risk who follow a Mediterranean diet. The researchers measured tartaric acid in urine to provide an objective measure of wine consumption, showing a greater protective effect than previous studies.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateDec 17, 2024

Teens with a reduced response to rewards are more susceptible to depression

Researchers found that a blunted response to reward feedback in teens predicts the first onset of depression, but not anxiety or suicidal ideation. This study contributes to understanding neural risk factors for mental health disorders and developing new methods to assess mental health risks.

SourceElsevier·JournalBiological Psychiatry Cognitive Neuroscience and Neuroimaging·TypeImaging analysis·DateDec 17, 2024

A simple plasma-based biomarker could predict liver fibrosis in Latino adolescents with obesity

Researchers discovered a novel combination of plasma-based biomarkers that can predict liver fibrosis in Latino adolescents with obesity. The study found that dihydroxyacetone phosphate (DHAP) and alanine transaminase (ALT) were significantly associated with fibrosis, suggesting a potential low-cost, noninvasive screening tool.

SourceChildren's Hospital Los Angeles·JournalJournal of Pediatric Gastroenterology and Nutrition·TypeExperimental study·DateDec 16, 2024

A new biomarker helps detect kidney fibrosis in transplant patients without invasive procedures

Researchers have identified a simpler and more accessible alternative to diagnosing kidney fibrosis in transplant patients: measuring vitronectin levels in urine. The study found that vitronectin levels were significantly higher in patients with fibrosis, and combining this measurement with traditional urine tests improved accuracy.

SourceGermans Trias i Pujol Research Institute·JournalJournal of Translational Medicine·TypeObservational study·DateDec 2, 2024

World’s most common heart valve disease linked to insulin resistance in large national study

Researchers found a novel link between aortic stenosis and insulin resistance, with certain biomarkers increasing the risk of the disease. The study's findings suggest that managing metabolic health could be a new approach to reduce the risk of AS and improve cardiovascular health in aging populations.

SourceTaylor & Francis Group·JournalAnnals of Medicine·TypeData/statistical analysis·DateNov 27, 2024

Paving the way for diagnostics

Researchers at the University of Jena have developed a method to functionalise graphene without interference, allowing for ultrasensitive detection of biomarkers. This breakthrough enables rapid, cost-effective diagnostics using graphene-based field-effect transistors.

SourceFriedrich-Schiller-Universitaet Jena·JournalAdvanced Materials·TypeExperimental study·DateNov 27, 2024

Phenotypic and epigenetic clocks for aging and mortality

This systematic review analyzes 33 biological clocks used for aging and mortality quantification, categorizing them into epigenetic and phenotypic clocks. Epigenetic clocks demonstrate precision in estimating chronological age through DNA methylation, while phenotypic clocks predict mortality using easily measurable clinical variables.

SourceImpact Journals LLC·JournalAging-US·TypeSystematic review·DateNov 20, 2024

Studies point to correlation between preeclampsia and COVID-19 in pregnant women

Research highlights correlation between preeclampsia and COVID-19 in pregnant women, identifying biomarkers for differential diagnosis. The review article emphasizes the pathophysiological similarities between the two conditions, including shared pathways involving the renin-angiotensin system and ACE2.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalAmerican Journal Of Reproductive Immunology·TypeLiterature review·DateNov 7, 2024

Combining the VIGex gene expression signature with liquid biopsy may improve response prediction to immunotherapy

Researchers have found that combining the VIGex gene expression signature with liquid biopsy analysis improves response prediction to immunotherapy in patients with advanced solid tumors. The study analyzed tumor samples and circulating tumor DNA (ctDNA) by liquid biopsy, showing that the VIGex-Hot subgroup was associated with higher o...

SourceVall d'Hebron Institute of Oncology·JournalJCO Precision Oncology·DateNov 7, 2024

Closing in on Parkinson’s Disease proteins in extracellular vesicles in the blood

Researchers have developed a new protocol to exclusively access and quantify proteins carried by extracellular vesicles in the blood. This breakthrough may lead to early diagnosis of Parkinson's disease and other brain disorders, providing treatment opportunities before symptoms appear.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 1, 2024